GHP Investment Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5K Hold
50
﹤0.01% 661
2026
Q1
$24K Hold
50
﹤0.01% 670
2025
Q4
$28.1K Hold
50
﹤0.01% 598
2025
Q3
$25.7K Hold
50
﹤0.01% 601
2025
Q2
$15.7K Hold
50
﹤0.01% 668
2025
Q1
$15.2K Hold
50
﹤0.01% 637
2024
Q4
$16.6K Hold
50
﹤0.01% 624
2024
Q3
$16.7K Hold
50
﹤0.01% 649
2024
Q2
$20.6K Hold
50
﹤0.01% 590
2024
Q1
$20.2K Hold
50
﹤0.01% 583
2023
Q4
$15.3K Hold
50
﹤0.01% 604
2023
Q3
$12K Hold
50
﹤0.01% 673
2023
Q2
$13.3K Hold
50
﹤0.01% 649
2023
Q1
$9.4K Hold
50
﹤0.01% 697
2022
Q4
$10.6K Hold
50
﹤0.01% 679
2022
Q3
$8K Hold
50
﹤0.01% 722
2022
Q2
$7K Hold
50
﹤0.01% 759
2022
Q1
$8K Buy
+50
New +$8.24K ﹤0.01% 759

Other funds holding MEDP

GHP Investment Advisors's MEDP Position: Q2 2026 in Review

GHP Investment Advisors held its Medpace (MEDP) position steady in Q2 2026 at 50 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #661.

GHP Investment Advisors first reported a position in MEDP in Q1 2022 and has held it in 18 quarters since. The position peaked at $28.1K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • GHP Investment Advisors held 50 shares of Medpace worth $26.5K as of Q2 2026.
  • GHP Investment Advisors left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #661 holding.
  • GHP Investment Advisors first reported a position in Medpace in Q1 2022 and has held it in 18 quarters since.
  • GHP Investment Advisors's Medpace position peaked at $28.1K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.